Display Options:
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Mineralocorticoid receptor agonist
ROUTE OF ADMINISTRATION: IMPLANTATION; INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: DNA inhibitor
ROUTE OF ADMINISTRATION: TOPICAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Amyotrophic Lateral Sclerosis; Eye Infections; Leishmaniasis; Trypanosomiasis
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Voltage-gated T-type calcium channel blocker
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Epilepsy
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Arachidonate 5-lipoxygenase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: DIABETES DRUGS & ENDOCRINOLOGY; OTHER; RHEUMATOLOGY
THERAPEUTIC INDICATION: Glioblastoma; Hypertension, Pulmonary; Intestinal Obstruction; Nausea; Cholangitis, Sclerosing; Peripheral Nervous System Diseases; Spondylitis, Ankylosing; Arthritis, Psoriatic; Arthritis, Juvenile; Arthritis, Rheumatoid; Colitis, Ulcerative
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: FOR RX COMPOUNDING; INJECTION; OPHTHALMIC; OTIC; RECTAL; TOPICAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Vitiligo; Dermatitis, Atopic; Eye Diseases; Hemorrhoids; Inflammation; Pruritus; Skin Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Enoyl-[acyl-carrier-protein] reductase inhibitor
ROUTE OF ADMINISTRATION: INJECTION; ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Melanoma; Acquired Immunodeficiency Syndrome; Diabetic Foot; Meningitis; Tuberculosis, Multidrug-Resistant; Ulcer; HIV Infections; Silicosis; Tuberculosis; Tuberculosis, Pulmonary
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Androgen Receptor agonist
ROUTE OF ADMINISTRATION: INJECTION; SUBCUTANEOUS
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Muscular Dystrophy, Facioscapulohumeral; HIV Wasting Syndrome; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Pulmonary Disease, Chronic Obstructive; Weight Loss; Hypogonadism
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Bacterial dihydropteroate synthase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Amidophosphoribosyltransferase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Burkitt Lymphoma; Astrocytoma; Brain Neoplasms; Colitis; Glioblastoma; Glioma; Leukemia, Lymphoid; Oligodendroglioma; Colitis, Ulcerative; Crohn Disease; Histiocytosis, Langerhans-Cell; Leukemia; Leukemia, Biphenotypic, Acute; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: INJECTION; OPHTHALMIC; ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Iritis; Macular Edema; Retinal Vein Occlusion; Cataract; Eye Infections; Low Back Pain; Sciatica; Uveitis; Uveitis, Anterior; Anemia; Conjunctivitis, Allergic; Corneal Injuries; Eye Diseases; Hemorrhoids; Inflammation; Multiple Sclerosis; Nasal Obstruction
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Mineralocorticoid receptor agonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Depressive Disorder; Adrenal Hyperplasia, Congenital; Melanoma; Ovarian Hyperstimulation Syndrome; Parkinson Disease; Severe Acute Respiratory Syndrome; Shock, Septic; Addison Disease; Adrenogenital Syndrome
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Addison Disease; Eye Diseases; Hemorrhoids
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Eye Diseases; Hemorrhoids; Nasal Obstruction
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: TOPICAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Estrogen receptor alpha agonist
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: DNA inhibitor
ROUTE OF ADMINISTRATION: INJECTION; ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Anemia; Biliary Tract Neoplasms; Breast Carcinoma In Situ; Carcinoma, Medullary; Carcinoma, Pancreatic Ductal; Chordoma; Colonic Neoplasms; Desmoplastic Small Round Cell Tumor; Diffuse Intrinsic Pontine Glioma; Fibroma; Fibrosarcoma; Glioblastoma; Glomerulosclerosis, Focal Segmental; HIV Infections; Head and Neck Neoplasms; Hepatoblastoma; Histiocytoma; Leukemia, Plasma Cell; Liposarcoma; Liposarcoma, Myxoid; Lymphoma, B-Cell; Muscular Diseases; Myasthenia Gravis; Mycosis Fungoides; Myoepithelioma; Nasopharyngeal Neoplasms; Nausea; Neoplasm Metastasis; Osteogenesis Imperfecta; Renal Insufficiency; Sarcoma, Clear Cell; Sarcoma, Synovial; Sezary Syndrome; Stiff-Person Syndrome; Thymoma; Urinary Bladder Neoplasms; Acquired Immunodeficiency Syndrome; Adrenoleukodystrophy; Anemia, Sickle Cell; Arthritis, Rheumatoid; Blast Crisis; Breast Neoplasms, Male; Carcinoma, Merkel Cell; Castleman Disease; Colorectal Neoplasms; Crohn Disease; Endometrial Neoplasms; Epidermolysis Bullosa; Esophageal Neoplasms; Fanconi Anemia; Fucosidosis; Gangliosidosis, GM1; Gaucher Disease; Glioma; Gliosarcoma; Granulomatous Disease, Chronic; Hematologic Diseases; Hematologic Neoplasms; Hereditary Breast and Ovarian Cancer Syndrome; Histiocytosis, Langerhans-Cell; IgA Vasculitis; Immune System Diseases; Immunoglobulin Light-chain Amyloidosis; Immunologic Deficiency Syndromes; Leukemia, Lymphoid; Leukemia, Myelomonocytic, Juvenile; Leukemia, Prolymphocytic; Leukodystrophy, Globoid Cell; Leukodystrophy, Metachromatic; Liver Neoplasms; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic; Lymphoma, AIDS-Related; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell; Lymphoproliferative Disorders; Mesothelioma; Mouth Neoplasms; Myelodysplastic-Myeloproliferative Diseases; Myeloproliferative Disorders; Neuroectodermal Tumors, Primitive, Peripheral; Neuroendocrine Tumors; Neuromyelitis Optica; Neuronal Ceroid-Lipofuscinoses; Niemann-Pick Diseases; Osteopetrosis; Osteosarcoma; Pancreatic Neoplasms; Peritoneal Neoplasms; Plasmacytoma; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Primary Myelofibrosis; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Purpura, Thrombocytopenic, Idiopathic; Rectal Neoplasms; Sandhoff Disease; Sarcoidosis; Skin Neoplasms; Squamous Intraepithelial Lesions; Takayasu Arteritis; Tay-Sachs Disease; Thalassemia; Thyroid Neoplasms; Tuberculosis; Uterine Cervical Neoplasms; Vasculitis; Wolman Disease; Adenocarcinoma; Amyloidosis; Amyloidosis, Familial; Anemia, Aplastic; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Behcet Syndrome; Bone Marrow Failure Disorders; Brain Neoplasms; Burkitt Lymphoma; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Central Nervous System Neoplasms; Choroid Plexus Neoplasms; Condylomata Acuminata; Ependymoma; Fallopian Tube Neoplasms; Ganglioneuroblastoma; Gestational Trophoblastic Disease; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Graft vs Host Disease; Granuloma, Lethal Midline; Granulomatosis with Polyangiitis; Idiopathic Pulmonary Fibrosis; Immunoblastic Lymphadenopathy; Infertility; Inflammatory Breast Neoplasms; Kidney Diseases; Kidney Neoplasms; Leukemia; Leukemia, Biphenotypic, Acute; Leukemia, Erythroblastic, Acute; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Megakaryoblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukemia, Myelomonocytic, Chronic; Leukemia-Lymphoma, Adult T-Cell; Lung Neoplasms; Lupus Nephritis; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Medulloblastoma; Melanoma; Menopause; Mesenchymoma; Microscopic Polyangiitis; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Myelodysplastic Syndromes; Neoplasms, Germ Cell and Embryonal; Neuroblastoma; Neuroectodermal Tumors, Primitive; Neutropenia; Ovarian Neoplasms; Pemphigus; Postoperative Nausea and Vomiting; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Fibrosis; Red-Cell Aplasia, Pure; Renal Insufficiency, Chronic; Retinoblastoma; Rhabdomyosarcoma; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Sarcoma; Sarcoma, Ewing; Scleritis; Scleroderma, Localized; Scleroderma, Systemic; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of Head and Neck; Testicular Neoplasms; Thrombocytopenia; Triple Negative Breast Neoplasms; Waldenstrom Macroglobulinemia; Wilms Tumor; Breast Neoplasms; Hodgkin Disease; Lymphoma; Multiple Myeloma; Neoplasms; Nephrotic Syndrome
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Bacterial 70S ribosome inhibitor
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Acne Vulgaris; Bacterial Infections; Eye Infections; Infections
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Epilepsy; Immune System Diseases; Myelodysplastic Syndromes; Chemical and Drug Induced Liver Injury; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Mast-Cell; Lymphoma, Non-Hodgkin; Multiple Myeloma; Pneumonia, Bacterial; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Deafness; Encephalitis, Japanese; Glomerulonephritis; Glomerulonephritis, IGA; Graft vs Host Disease; Leukemia, Myeloid, Acute; Multiple Sclerosis, Chronic Progressive; Pain; Pneumonia; Severe Acute Respiratory Syndrome; Vestibular Neuronitis; Acne Vulgaris; Anemia; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Asthma; Bursitis; Dermatitis; Endocrine System Diseases; Inflammation; Leukemia; Lymphoma; Multiple Sclerosis; Osteoarthritis; Serum Sickness; Uveitis, Posterior
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Androgen Receptor agonist
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Eye Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: INJECTION; ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Eye Diseases; Hemorrhoids; Lung Diseases, Obstructive; Nasal Obstruction
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Eye Diseases; Hemorrhoids
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Adrenergic receptor alpha-2 agonist
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Dry Eye Syndromes; Osteoarthritis; Periarthritis; Tendinopathy; Colitis, Ulcerative; Eye Diseases; Hemorrhoids; Lung Diseases, Obstructive; Nasal Obstruction
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Enoyl-[acyl-carrier-protein] reductase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tuberculosis
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: DNA inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Infections; Urinary Tract Infections
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Dopamine D2 receptor antagonist
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Psoriasis; Anxiety; Dementia; Depressive Disorder; Schizophrenia; Psychotic Disorders
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: TOPICAL
STATUS: Approved
THERAPEUTIC AREA: DERMATOLOGY; OTHER
THERAPEUTIC INDICATION: Psoriasis; Dermatitis, Atopic; Oral Submucous Fibrosis; Eye Diseases; Hemorrhoids; Lung Diseases, Obstructive; Nasal Obstruction; Skin Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Peroxisome proliferator-activated receptor alpha agonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Myocardial Infarction; Myocardial Ischemia; Cardiovascular Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Amidophosphoribosyltransferase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Inflammatory Bowel Diseases; Mucopolysaccharidoses; Myelodysplastic Syndromes; Urticaria; Anemia, Sickle Cell; Gout; Hepatitis, Autoimmune; Idiopathic Pulmonary Fibrosis; Infertility; Leukemia, Myeloid, Acute; Lung Diseases; Lung Diseases, Interstitial; Pemphigoid, Bullous; Pemphigus; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Carcinoma, Hepatocellular; Cardiomyopathies; Churg-Strauss Syndrome; Colitis, Ulcerative; Crohn Disease; Eczema; Encephalomyelitis; Glomerulonephritis, IGA; Granulomatosis with Polyangiitis; Lupus Erythematosus, Systemic; Lupus Nephritis; Microscopic Polyangiitis; Myasthenia Gravis; Neuromyelitis Optica; Pulmonary Fibrosis; Renal Insufficiency, Chronic; Takayasu Arteritis; Thrombocytopenia; Vasculitis; Arthritis, Rheumatoid; Immune System Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Anandamide amidohydrolase inhibitor
ROUTE OF ADMINISTRATION: INJECTION; INTRAVENOUS; ORAL; RECTAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Arrhythmias, Cardiac; Crohn Disease; Diabetes Mellitus, Type 2; Glycogen Storage Disease Type II; Hepatitis B, Chronic; Immune System Diseases; Intervertebral Disc Degeneration; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Nervous System Diseases; Obesity, Morbid; Parkinson Disease; Pruritus; Purpura, Thrombocytopenic, Idiopathic; Anxiety; Arthritis, Rheumatoid; Borderline Personality Disorder; Brain Injuries; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cleft Palate; Diabetes Mellitus, Type 1; Digestive System Diseases; Fractures, Bone; Glioma; Graft vs Host Disease; Head and Neck Neoplasms; Hypertension; Hypertrophy; Immunoglobulin G4-Related Disease; Leukemia, Mast-Cell; Leukemia, Myeloid, Acute; Leukemia, T-Cell; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Melanoma; Mucositis; Multiple Myeloma; Myelodysplastic Syndromes; Neck Pain; Neuralgia; Pre-Eclampsia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pulpitis; Renal Colic; Rotator Cuff Injuries; Sinusitis; Tension-Type Headache; Tonsillitis; Abdominal Pain; Chronic Pain; Delirium; Diabetic Neuropathies; Ductus Arteriosus, Patent; HIV Infections; Hemorrhage; Hypospadias; Infections; Kidney Calculi; Kidney Diseases; Low Back Pain; Lupus Erythematosus, Systemic; Lupus Nephritis; Malaria; Malaria, Falciparum; Meningitis, Bacterial; Multiple Sclerosis; Myopia; Nausea; Neoplasms; Obesity; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Paget Disease, Extramammary; Pemphigus; Postoperative Nausea and Vomiting; Respiratory Tract Infections; Scoliosis; Sepsis; Severe Acute Respiratory Syndrome; Streptococcal Infections; Vomiting; Wounds and Injuries; Acute Pain; Arthritis; Back Pain; Common Cold; Dysmenorrhea; Fever; Headache; Influenza, Human; Migraine Disorders; Muscle Cramp; Pain; Pharyngitis; Toothache
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Glioblastoma; Central Nervous System Neoplasms; Hodgkin Disease; Lymphoma; Neoplasms
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Arthritis, Rheumatoid; Joint Diseases; Pain; Eye Diseases; Hemorrhoids; Lung Diseases, Obstructive; Nasal Obstruction; Osteoarthritis
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Thymidylate synthase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Astrocytoma; Carcinoma, Hepatocellular; Colorectal Neoplasms; Gliosarcoma; Neoplasms; Oligodendroglioma; Intracranial Hypertension; Meningitis, Cryptococcal; Candidiasis; Infections; Meningitis